UP!
| 2016-06-29 | Reiterated Rating | BTIG Research | Buy | $35.00 |
| 2016-06-28 | Reiterated Rating | Stifel Nicolaus | Buy | |
| 2016-06-17 | Reiterated Rating | Mizuho | Neutral | $20.00 |
| 2016-06-16 | Reiterated Rating | Cantor Fitzgerald | Buy | $41.00 |
| 2016-06-16 | Reiterated Rating | BTIG Research | Buy | $35.00 |
| 2016-06-16 | Reiterated Rating | Wedbush | Outperform to Outperform | $51.00 |
| 2016-06-10 | Reiterated Rating | Wedbush | Buy | |
| 2016-06-07 | Downgrade | Morgan Stanley | Equal Weight to Underweight | $9.00 |
| 2016-06-04 | Reiterated Rating | Wedbush | Buy | $51.00 |
| 2016-06-01 | Reiterated Rating | HC Wainwright | Buy | $32.00 |
| 2016-06-01 | Upgrade | Mizuho | Underperform to Neutral | $12.00 to $20.00 |
| 2016-05-31 | Reiterated Rating | Oppenheimer | Outperform | $36.00 |
| 2016-05-31 | Reiterated Rating | Oppenheimer Holdings Inc. | Outperform | $36.00 |
| 2016-05-29 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2016-05-29 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-05-29 | Reiterated Rating | BTIG Research | Buy | $35.00 |
| 2016-05-29 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-05-27 | Reiterated Rating | Mizuho | Underperform | $12.00 |
| 2016-05-27 | Reiterated Rating | Wedbush | Outperform | $51.00 |
| 2016-05-23 | Upgrade | Morgan Stanley | Underweight to Equal Weight | $9.00 |
| 2016-05-18 | Reiterated Rating | Wedbush | Outperform | $51.00 |
| 2016-05-17 | Reiterated Rating | HC Wainwright | Buy | $32.00 |
| 2016-05-17 | Reiterated Rating | BTIG Research | Buy | $35.00 |
| 2016-05-17 | Reiterated Rating | Morgan Stanley | Sell | |
| 2016-05-17 | Reiterated Rating | Mizuho | Underperform | $12.00 |
| 2016-05-17 | Reiterated Rating | Brean Capital | Buy | $26.00 |
| 2016-05-17 | Reiterated Rating | Citigroup Inc. | Buy | $30.00 to $25.00 |
| 2016-05-16 | Reiterated Rating | Cantor Fitzgerald | Buy | $41.00 |
| 2016-05-09 | Reiterated Rating | HC Wainwright | Buy | $36.00 to $32.00 |
| 2016-05-09 | Lower Price Target | Wedbush | Outperform | $52.00 to $51.00 |
| 2016-05-07 | Reiterated Rating | Brean Capital | Buy | $26.00 |
| 2016-05-05 | Reiterated Rating | Morgan Stanley | Sell | |
| 2016-05-05 | Lower Price Target | BTIG Research | Buy | $45.00 to $35.00 |
| 2016-05-04 | Downgrade | Mizuho | Neutral to Underperform | $22.00 to $12.00 |
| 2016-05-04 | Reiterated Rating | Cantor Fitzgerald | Buy | $42.00 |
| 2016-04-26 | Lower Price Target | HC Wainwright | Buy | $63.00 to $36.00 |
| 2016-04-25 | Reiterated Rating | Mizuho | Neutral | $22.00 |
| 2016-04-17 | Reiterated Rating | Brean Capital | Buy | $26.00 |
| 2016-04-17 | Reiterated Rating | Mizuho | Hold | |
| 2016-04-17 | Reiterated Rating | BTIG Research | Buy | $45.00 |
| 2016-04-17 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-04-16 | Reiterated Rating | Morgan Stanley | Underweight | $9.00 |
| 2016-04-12 | Initiated Coverage | Mizuho | Neutral | $22.00 |
| 2016-04-10 | Reiterated Rating | Cantor Fitzgerald | Buy | $42.00 |
| 2016-04-09 | Reiterated Rating | Wedbush | Outperform | $52.00 |
| 2016-04-09 | Reiterated Rating | BTIG Research | Buy | $45.00 |
| 2016-04-01 | Reiterated Rating | Oppenheimer | Buy | $55.00 to $44.00 |
| 2016-04-01 | Initiated Coverage | Raymond James | Market Perform | |
| 2016-04-01 | Initiated Coverage | Raymond James Financial Inc. | Market Perform | |
| 2016-03-29 | Initiated Coverage | Brean Capital | Buy | $26.00 |
| 2016-03-17 | Reiterated Rating | Cantor Fitzgerald | Buy | $42.00 |
| 2016-03-16 | Reiterated Rating | Wedbush | Outperform | $53.00 to $52.00 |
| 2016-03-16 | Reiterated Rating | BTIG Research | Buy | $45.00 |
| 2016-03-16 | Reiterated Rating | Morgan Stanley | Underweight | $9.00 |
| 2016-03-16 | Reiterated Rating | Citigroup Inc. | Buy | $38.00 to $30.00 |
| 2016-02-26 | Reiterated Rating | Cantor Fitzgerald | Buy | $42.00 |
| 2016-02-25 | Reiterated Rating | Bank of America | Buy | $32.00 to $29.00 |
| 2016-02-25 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-02-25 | Reiterated Rating | BTIG Research | Buy | $45.00 |
| 2016-02-25 | Lower Price Target | Stifel Nicolaus | Buy | $40.00 to $36.00 |
| 2016-02-25 | Lower Price Target | Wedbush | Outperform | $86.00 to $53.00 |
| 2016-02-25 | Reiterated Rating | Bank of America Corp. | Buy | $32.00 to $29.00 |
| 2016-02-19 | Lower Price Target | Citigroup Inc. | $45.00 to $38.00 | |
| 2016-02-14 | Reiterated Rating | HC Wainwright | Buy | $63.00 |
| 2016-02-10 | Reiterated Rating | BTIG Research | Buy | $45.00 |
| 2016-01-30 | Initiated Coverage | Oppenheimer | Outperform | $55.00 |
| 2016-01-27 | Reiterated Rating | Cantor Fitzgerald | Buy | $42.00 |
| 2016-01-26 | Reiterated Rating | BTIG Research | Buy | $45.00 |
| 2016-01-26 | Reiterated Rating | Wedbush | Outperform | $86.00 |
| 2016-01-26 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-01-21 | Reiterated Rating | Oppenheimer | Outperform | $55.00 |
| 2016-01-05 | Initiated Coverage | BTIG Research | Buy | $45.00 |
| 2016-01-03 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2015-12-28 | Reiterated Rating | Cantor Fitzgerald | Buy | $42.00 |
| 2015-12-27 | Reiterated Rating | Oppenheimer | Buy | |
| 2015-12-22 | Reiterated Rating | Wedbush | Outperform | $75.00 to $86.00 |
| 2015-12-21 | Reiterated Rating | Oppenheimer | Buy | $55.00 |
| 2015-12-17 | Initiated Coverage | HC Wainwright | Buy | $63.00 |
| 2015-12-09 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2015-12-08 | Reiterated Rating | Wedbush | Buy | $75.00 |
| 2015-12-07 | Reiterated Rating | Bank of America | Buy | $27.00 |
| 2015-12-04 | Reiterated Rating | Stifel Nicolaus | Buy | |
| 2015-12-03 | Reiterated Rating | Cantor Fitzgerald | Buy | $42.00 |
| 2015-11-10 | Reiterated Rating | Oppenheimer | Outperform | $55.00 |
| 2015-11-09 | Boost Price Target | Cantor Fitzgerald | Buy | $36.00 to $42.00 |
| 2015-11-07 | Reiterated Rating | Citigroup Inc. | Buy | $45.00 |
| 2015-11-04 | Initiated Coverage | Guggenheim | Buy | $46.00 |
| 2015-11-03 | Reiterated Rating | Oppenheimer | Buy | $55.00 |
| 2015-10-27 | Reiterated Rating | Nomura | Outperform | $75.00 |
| 2015-10-27 | Reiterated Rating | Nomura Holdings Inc. | Outperform | $75.00 |
| 2015-10-26 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2015-10-26 | Reiterated Rating | Oppenheimer | Outperform | $55.00 |
| 2015-10-22 | Reiterated Rating | Wedbush | Buy | $66.00 to $75.00 |
| 2015-10-14 | Reiterated Rating | Oppenheimer | Buy | $55.00 |
| 2015-09-17 | Reiterated Rating | Oppenheimer | Outperform | $55.00 |
| 2015-09-08 | Reiterated Rating | Oppenheimer | Buy | $55.00 |
| 2015-09-03 | Initiated Coverage | Citigroup Inc. | Buy | $45.00 |
| 2015-08-13 | Initiated Coverage | Morgan Stanley | Underweight | $15.00 |
| 2015-08-11 | Reiterated Rating | Wedbush | Buy | |
| 2015-08-10 | Reiterated Rating | Stifel Nicolaus | Buy | $50.00 to $48.00 |
| 2015-08-07 | Reiterated Rating | Oppenheimer | Outperform | $55.00 |
| 2015-07-30 | Initiated Coverage | Oppenheimer | Outperform | $60.00 to $55.00 |
| 2015-07-06 | Initiated Coverage | Cantor Fitzgerald | Buy | $42.00 |
| 2015-05-08 | Set Price Target | Wedbush | Outperform | $64.00 to $66.00 |
| 2015-03-12 | Reiterated Rating | Wedbush | Outperform | $64.00 |
| 2015-03-09 | Reiterated Rating | Oppenheimer | Outperform | $60.00 |
| 2015-02-27 | Reiterated Rating | Wedbush | Outperform | $63.00 |
| 2015-01-27 | Set Price Target | Wedbush | Buy | $63.00 |
| 2015-01-09 | Boost Price Target | Stifel Nicolaus | Buy | $47.00 to $55.00 |
| 2015-01-05 | Reiterated Rating | Wedbush | Outperform | $63.00 |
| 2014-12-15 | Initiated Coverage | Bank of America | Buy | $55.00 |
| 2014-12-04 | Initiated Coverage | Oppenheimer | Outperform | $60.00 |
| 2014-09-16 | Reiterated Rating | Wedbush | Buy | |
| 2014-08-12 | Boost Price Target | Stifel Nicolaus | Buy | $45.00 to $47.00 |
| 2014-05-13 | Boost Price Target | Wedbush | Outperform | $56.00 to $57.00 |
| 2014-05-08 | Reiterated Rating | Stifel Nicolaus | Buy | $49.00 to $45.00 |
| 2014-03-18 | Reiterated | Stifel | Buy | $41 to $49 |
| 2014-03-18 | Reiterated | Sterne Agee | Buy | $41 to $49 |
| 2014-03-18 | Reiterated | Stif | ||
| 2014-03-18 | Boost Price Target | Stifel Nicolaus | Buy | $41.00 to $49.00 |
| 2014-03-18 | Boost Price Target | Sterne Agee CRT | Buy | $41.00 to $49.00 |
| 2014-02-11 | Reiterated | Stifel | Buy | $25 to $41 |
| 2014-02-11 | Boost Price Target | Wunderlich | Buy | $25.00 to $41.00 |
| 2014-02-11 | Boost Price Target | Stifel Nicolaus | Buy | $25.00 to $41.00 |
| 2013-12-12 | Initiated Coverage | B. Riley | Buy | |
| 2013-12-12 | Initiated Coverage | Bank of America | Buy | $40.00 |
| 2013-12-10 | Initiated Coverage | Cowen and Company | Outperform | |
| 2013-12-10 | Initiated Coverage | Stifel Nicolaus | Buy | $25.00 |
| 2013-12-10 | Initiated Coverage | Wedbush | Outperform | $34.00 |
| 2013-12-10 | Initiated Coverage | Morgan Stanley | Overweight | $57.00 |
| 2016-06-29 | Reiterated Rating | BTIG Research | Buy | $35.00 |
| 2016-06-28 | Reiterated Rating | Stifel Nicolaus | Buy | |
| 2016-06-17 | Reiterated Rating | Mizuho | Neutral | $20.00 |
| 2016-06-16 | Reiterated Rating | Cantor Fitzgerald | Buy | $41.00 |
| 2016-06-16 | Reiterated Rating | BTIG Research | Buy | $35.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In RLYP 2 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Schonfeld Group Holdings LLC | 12500 |
| BOSTON PRIVATE BANK & TRUST CO | 600 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| SILVERSTEIN JONATHAN | 29.24% (9941551) | ICPT / RLYP / ROKA / |
| ORBIMED ADVISORS LLC | 9.87% (3356400) | AGLE / AMBI / ANTH / ATHX / BOLD / BONE / CRVS / CTIC / ICPT / KALA / LOXO / MRTX / OTIC / RLYP / ROKA / SIEN / SUPN / SYBX / XLRN / |
| HUNT RONALD Former 10% beneficial owner | 6.22% (2114890) | DRTX / RLYP / |
| New Leaf Ventures I, L.P. Former 10% beneficial owner | 6.22% (2114890) | CNCE / RLYP / TSPT / |
| DONDERO JAMES D | 0.38% (128500) | NXRT / PCO / RLYP / |
| ROCKLAGE SCOTT M | 0.18% (62316) | AKAO / EPRS / RLYP / RTGN / |
| Orwin John A President & CEO | 0.16% (53892) | AFFY / ARRY / RLYP / SGEN / |
| 5AM Partners II, LLC | 0.15% (50082) | RLYP / |
| 5AM Partners III, LLC | 0.14% (47502) | BOLD / EPRS / RLYP / |
| Schuetz Thomas J. | 0.11% (36212) | BOLD / RLYP / |
| BALL KRISTINE M Chief Financial Officer & SVP | 0.08% (28110) | MNLO / RLYP / |
| Berman Lance Chief Medical Officer and SVP | 0.06% (21110) | RLYP / |
| Harrison Stephen D SVP & Chief Scientific Officer | 0.05% (17844) | RLYP / |
| Corbett Mary Senior VP, Human Resources | 0.05% (17330) | RLYP / |
| Stahl Wilhelm SVP, Pharmaceutical Operations | 0.04% (14729) | RLYP / |
| Krasnow Ronald A. See Remarks | 0.04% (14729) | RLYP / |
| Garland J. Scott SVP & Chief Commercial Officer | 0.04% (14345) | EXEL / KPTI / RLYP / |
| Montgomery Monte Chief Accounting Officer | 0.04% (12539) | RLYP / |
| Lockey Claire See Remarks | 0.03% (10478) | RLYP / |
| Butler John P. | 0.01% (5099) | AKBA / KERX / RLYP / |
| MCGIRR DAVID W J | 0.01% (4979) | INSM / RLYP / ROKA / |
| HASTINGS PAUL J | 0.01% (4745) | OMED / PCRX / PRTO / RLYP / |
| SPIEGELMAN DANIEL K | 0.01% (3487) | AFFY / ANTH / BMRN / CYCC / OMER / ONTY / RLYP / |
| Torley Helen | 0.01% (3487) | HALO / RLYP / |
| Hillan Kenneth J. | 0.01% (3487) | AKAO / RLYP / |
| VEITINGER KLAUS R DR | 0.01% (2712) | ICPT / RLYP / |
UM